Health Canada
- Status: approved
IPV at 14 and fIPV at 22 weeks, Rotarix (IPV at 14 and fIPV at 22 weeks, Rotarix) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Centers for Disease Control and Prevention is the originator. The local marketing authorisation holder may differ — check the official source linked above.